BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8963768)

  • 21. [Research progression on complement regulatory proteins CD46, CD55, and CD59 in tumor immunotherapy].
    Qin C; Cai XY
    Ai Zheng; 2006 Nov; 25(11):1450-3. PubMed ID: 17094920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.
    Murray KP; Mathure S; Kaul R; Khan S; Carson LF; Twiggs LB; Martens MG; Kaul A
    Gynecol Oncol; 2000 Feb; 76(2):176-82. PubMed ID: 10637067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement regulatory proteins and autoimmunity.
    Kawano M
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):367-72. PubMed ID: 11140463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
    Ravindranath NM; Shuler C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part II: xenogeneic perfusion of the porcine liver in vivo.
    Shiraishi M; Oshiro T; Nozato E; Nagahama M; Taira K; Nomura H; Sugawa H; Muto Y
    Transpl Int; 2002 May; 15(5):212-9. PubMed ID: 12012041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic defense mechanism of non-antibody-dependent complement reactions].
    Nomoto K
    Nihon Rinsho; 1988 Sep; 46(9):1949-54. PubMed ID: 2468005
    [No Abstract]   [Full Text] [Related]  

  • 28. Ethical considerations in clinical cardiac xenografting.
    Pierson RN; White DJ; Wallwork J
    J Heart Lung Transplant; 1993; 12(5):876-8. PubMed ID: 7694655
    [No Abstract]   [Full Text] [Related]  

  • 29. [Functions and structure of complement inactivators in membrane proteins. 2). Decay-accelerating factor].
    Sugita Y
    Nihon Rinsho; 1988 Sep; 46(9):1927-32. PubMed ID: 2468004
    [No Abstract]   [Full Text] [Related]  

  • 30. Human complement regulators: a major target for pathogenic microorganisms.
    Lindahl G; Sjöbring U; Johnsson E
    Curr Opin Immunol; 2000 Feb; 12(1):44-51. PubMed ID: 10679403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of membrane cofactor protein analysis].
    Seya T
    Nihon Rinsho; 1990 Feb; 48 Suppl():673-6. PubMed ID: 2355591
    [No Abstract]   [Full Text] [Related]  

  • 32. Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor.
    Atkinson JP; Oglesby TJ; White D; Adams EA; Liszewski MK
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):27-30. PubMed ID: 1718640
    [No Abstract]   [Full Text] [Related]  

  • 33. Complement receptor type 1.
    Ross GD
    Curr Top Microbiol Immunol; 1992; 178():31-44. PubMed ID: 1424775
    [No Abstract]   [Full Text] [Related]  

  • 34. [Molecular mechanisms for the regulation of nervous systems with glycosphingolipids].
    Furukawa K; Ohmi Y; Ohkawa Y; Tokuda N; Tajima O; Furukawa K
    Seikagaku; 2011 Mar; 83(3):169-78. PubMed ID: 21516682
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulation of complement by membrane proteins: an overview.
    Parker CJ
    Curr Top Microbiol Immunol; 1992; 178():1-6. PubMed ID: 1424770
    [No Abstract]   [Full Text] [Related]  

  • 36. Heterogeneity of interactions mediated by membrane glycoproteins of lymphocytes.
    Barclay AN; Brown MH
    Biochem Soc Trans; 1997 Feb; 25(1):224-8. PubMed ID: 9056875
    [No Abstract]   [Full Text] [Related]  

  • 37. More about use of the term Drb.
    Lewis M; McAlpine PJ
    Transfusion; 1993 Feb; 33(2):182. PubMed ID: 7679228
    [No Abstract]   [Full Text] [Related]  

  • 38. CD antigens 2001: aims and results of HLDA Workshops.
    Mason D; André P; Bensussan A; Buckley C; Civin C; Clark E; de Haas M; Goyert S; Hadam M; Hart D; Horejsí V; Meuer S; Morrissey J; Schwartz-Albiez R; Shaw S; Simmons D; Uguccioni M; van der Schoot E; Vivier E; Zola H
    Stem Cells; 2001; 19(6):556-62. PubMed ID: 11713348
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complement regulatory membrane factors in experimental animal models].
    Okada N
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):631-3. PubMed ID: 8963768
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kidney and complement regulatory factors].
    Matsuo S
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):643-6. PubMed ID: 8963771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.